Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy

NCT06008405 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: TQB2928 Injection + Azacitidine for injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.